Andre Knapp
Nurse Practitioner · Lafayette, LANPI 1407859937
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 341 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Viiv Healthcare Company at 43.0% of the total. 2025 is the largest year on record at $3,060, 5.7 times the $539 reported in 2022. Among nurse practitioner clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 341 payments — averaging $23.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$3K
- Gilead$2K
- Merck$608
- Theratechnologies Inc.$469
- Alkermes, Inc.$452
- Otsuka America Pharmaceutical, Inc.$286
- plus $644 from 7 others
What the payments were for
- Food & beverage$8,104100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 152 | $3,482 |
| Gilead | 89 | $2,164 |
| Merck | 29 | $608 |
| Theratechnologies Inc. | 13 | $469 |
| Alkermes, Inc. | 14 | $452 |
| Otsuka America Pharmaceutical, Inc. | 10 | $286 |
| Braeburn Inc. | 13 | $217 |
| Johnson & Johnson(2 entities) | 10 | $167 |
| EMD Serono, Inc. | 4 | $104 |
| Indivior Inc. | 3 | $69 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Seqirus USA Inc | 1 | $22 |
| Exact Sciences | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,104 in reported general payments places this provider in the 95th percentile of 969 nurse practitioner providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 218 | $863,822 |
| CabenuvaCabotegravir/Rilpivirine | 55 | $277,604 |
| DovatoDolutegravir Sodium/Lamivudine | 75 | $219,823 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 42 | $196,139 |
| TivicayDolutegravir Sodium | 61 | $137,987 |
| PrezcobixDarunavir/Cobicistat | 34 | $85,487 |
| DescovyEmtricitabine/Tenofov Alafenam | 31 | $69,456 |
| JulucaDolutegravir/Rilpivirine | 17 | $58,386 |
| JanuviaSitagliptin Phosphate | 22 | $14,269 |
| JardianceEmpagliflozin | 12 | $6,819 |
| Emtricitabine-Tenofovir DisopEmtricitabine/Tenofovir (Tdf) | 14 | $5,016 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 21 | $3,842 |
| Gabapentin | 65 | $1,071 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 41 | $981 |
| Rosuvastatin Calcium | 102 | $401 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $2,164 | $933,278249 claims |
| Viiv Healthcare CompanyCabenuva, Dovato, Tivicay, Juluca | $3,482 | $693,800208 claims |
| Johnson & JohnsonPrezcobix | $167 | $85,48734 claims |
| MerckJanuvia | $608 | $14,26922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 969 nurse practitioner providers in Louisiana.
Other nurse practitioner in Lafayette
- Karen DeshotelLafayette$264K
- Matt LandryLafayette$50K
- Cynthia CobbLafayette$48K
- Mareesa MathersLafayette$10K
- Paula MitchellLafayette$8K
- Emily LevyLafayette$8K
- Craig ManzerLafayette$7K
- Kellie WestLafayette$7K
- Courtney LafleurLafayette$6K
- Christopher ManuelKaplan$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.